Poor
Not Aligned
Patient Risk:
Medium
Summary
Several extracted claims are only partially supported and multiple determinations rely on incomplete label coverage from the provided excerpts; at least one claim is potentially inaccurate/unsupported due to insufficient basis for an 'absent from the label' conclusion.
Category Scores
Accurate Statements
Adderall is a brand name for a combination of amphetamine and dextroamphetamine.
DESCRIPTION: "A single-entity amphetamine product combining the neutral sulfate salts of dextroamphetamine and amphetamine..."
Adderall is prescribed to treat attention-deficit/hyperactivity disorder (ADHD).
INDICATIONS AND USAGE: indicated for "Attention Deficit Hyperactivity Disorder (ADHD)"
Adderall is prescribed to treat narcolepsy.
INDICATIONS AND USAGE: indicated for "Narcolepsy"
Adderall's stimulant properties can lead to misuse and abuse.
DRUG ABUSE AND DEPENDENCE: "has a high potential for abuse and misuse"; also refers to "Misuse and abuse of CNS stimulants, including Adderall®"
Using Adderall without a prescription carries significant health risks including potential for addiction.
DRUG ABUSE AND DEPENDENCE: misuse/abuse "can lead to the development of a substance use disorder, including addiction"
Unsupported Statements
Adderall is a central nervous system stimulant.
The prompt’s provided label excerpts do not explicitly support the categorical phrasing; only misuse/abuse of "CNS stimulants" is shown, and the excerpt set is insufficient to verify the definitional statement.
Adderall works by affecting the balance of certain natural substances in the brain.
No mechanism statement matching this wording is present in the provided label sections.
Illicit demand contributes to Adderall's availability outside of legitimate prescription channels.
The provided label excerpt supports diversion into illicit channels, but does not attribute availability to 'illicit demand.'
Using Adderall without a prescription carries significant health risks including cardiovascular problems.
No cardiovascular risk related to non-prescription use is supported by the provided label excerpts.
Using Adderall without a prescription carries significant health risks including psychiatric issues.
No psychiatric risk related to non-prescription use is supported by the provided label excerpts.
The purity and dosage of street-sold Adderall can be inconsistent.
No support in the provided label excerpts.
Possessing or distributing Adderall without a valid prescription is illegal.
The provided label excerpts do not state legality of possession/distribution (FDA labeling excerpt focuses on diversion).
Adderall is a Schedule II controlled substance in the United States.
No scheduling information is included in the provided label excerpts.
Schedule II controlled substances indicate a high potential for abuse.
The provided label excerpts do not state this interpretation/rationale.
Contradictions
Important Omissions
No evaluation against contraindications, warnings/precautions, drug interactions, adverse reactions, and administration/storage instructions for the extracted safety-related claims beyond abuse/misuse/addiction; the excerpt set includes contraindications but the extracted claims were not assessed against specific contraindication/warning content.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
Multiple extracted safety claims (cardiovascular, psychiatric, street formulation purity, legality/scheduling rationale) are not supported by the provided label excerpts, which could misstate label-grounded risks.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Aligned
Primary Issue
Several claims are not supported by the provided prescribing information excerpts, and at least one claim’s 'absent from the label' basis is not reliably established from the excerpt set.
Suggested Improvement
Restrict claims to those explicitly supported by the provided label sections (e.g., indications and abuse/misuse/addiction language), and remove or rephrase unsupported statements (CNS stimulant definition, mechanism, cardiovascular/psychiatric risks, street purity/dosage, legality, scheduling rationale) unless supported by additional label text.